Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors Meeting Abstract
| Authors: | Perreault, S.; Drilon, A.; Lassen, U. N.; Geoerger, B.; Nysom, K.; Øra, I.; Gavrilovic, I. T.; Norenberg, R.; Bernard-Gauthier, V.; De La Cuesta, E.; Laetsch, T. W.; Doz, F.; Van Tilburg, C. M. |
| Abstract Title: | Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors |
| Meeting Title: | 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 24 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Nov 16-20 |
| Meeting Location: | Tampa Bay, FL |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-11-01 |
| Start Page: | vii87 |
| Language: | English |
| ACCESSION: | WOS:000888571000330 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noac209.327 |
| Notes: | Meeting Abstract: CTNI-62 -- Source: Wos |
